Medical Devices

Aussie biotech ENA Respiratory secures crucial US patents for its novel immune modulator, signaling a major strategic move in the multi-billion dollar fight against COPD.

As Southeast Asia races to become an EV powerhouse, the real challenge lies on the factory floor. A new wave of traceable assembly tech aims to solve it.

A breakthrough publication identifies a novel protein, LanCL1, as a key target for neuropathic pain, validating a new class of drugs for millions of sufferers.

Sanofi's latest FDA nod for Tzield isn't just a new drug approval; it's a strategic shift from symptom management to disease modification in Type 1 Diabetes.

A small business's tip-off led to a federal crackdown on procurement fraud, revealing deep vulnerabilities and renewing the push for a secure American supply chain.

A major data breach at Ohio Living exposes sensitive patient and employee data, echoing a past failure and signaling a deepening crisis for the entire sector.

A Chicago jury's landmark verdict reveals how a single day's delay can lead to a lifetime of paralysis, questioning the very fabric of patient safety.

MBX Biosciences' new one-year data for canvuparatide isn't just a clinical win; it's a calculated move to dominate a billion-dollar market left vacant.

A Korean materials firm just won a top Boeing award. We go beyond the press release to reveal how it’s fortifying global supply chains and reshaping Asia's aerospace hub.

A new FDA-designated device aims to filter a deadly protein from the blood of sepsis patients. Can this novel approach finally conquer a global health crisis?

With a $20M Series A led by L Catterton, Dr. Muneeb Shah's REMEDY is disrupting skincare. Here's how accessible science is winning over consumers.

SIG SAUER, known for its U.S. military contracts, is pivoting to high-tech warfare with drones and remote weapons, signaling a major industry shift.

As Seattle welcomes the World Cup, Walgreens is doing more than selling souvenirs. It's a strategic move to capture a transient market with on-demand health services.

By acquiring RHE Container, President Container Group merges patented designs with massive, solar-powered manufacturing to dominate high-end apparel packaging.

Probiogen's 'Probiotic of the Year' award isn't just a win for the brand; it marks a pivotal moment for functional supplements and conscious consumerism.

KPJ Healthcare launches a kidney transplant service, a strategic move addressing a national health crisis and reviving a fifty-year-old medical legacy.

For decades, the egg industry has culled millions of male chicks. NestFresh says it has stopped. A look at the tech, the cost, and a potential moral revolution.

ATI's extended deal with BWXT isn't just a materials contract; it's the strategic bedrock for the U.S. Navy's global dominance and nuclear superiority.

Vivos Therapeutics' unusual rights offering isn't a simple plea for cash. It's a bold wager on its own turnaround and a case study in small-cap survival.

Paradisus La Perla's new WITT certification isn't just an award; it's a strategic move by Meliá to capture the booming $1.3T wellness travel market.